HomePharma

Pharma

Pharma

AVM Biotechnology Announces Twenty-Eight (28) Solid Tumor and Blood Cancer Patients have been Treated with Immunomodulatory AVM0703 through Expanded Access/Compassionate Use Programs

Life Sciences Times - 0
Pharma

FDA Approves Harm Reduction Therapeutics’ Over-the-Counter Opioid Overdose Reversal Medication

Life Sciences Times - 0
Pharma

Melinta Therapeutics Announces Commercial Availability of REZZAYO™

Life Sciences Times - 0
Pharma

Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease

Life Sciences Times - 0
Pharma

FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis

Life Sciences Times - 0
Pharma

First Patient Dosed in SAR’514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma

Life Sciences Times - 0
Pharma

U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease

Life Sciences Times - 0
Pharma

Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Life Sciences Times - 0
Pharma

Novaliq Announces FDA Approval of VEVYE™ (Cyclosporine Ophthalmic Solution) 0.1% for the Treatment of the Signs and Symptoms of Dry Eye Disease

Life Sciences Times - 0
Pharma

INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure

Life Sciences Times - 0
Pharma

Myrtelle to Present Positive 6-month Post-Treatment Data in Its First-in-Human Clinical Study of rAAV-Olig001-ASPA Gene Therapy in Canavan Disease at the National Tay-Sachs and...

Life Sciences Times - 0
Pharma

Lyndra Therapeutics Presents Data on Long-Acting Oral Weekly Risperidone (LYN-005) at American Society of Clinical Psychopharmacology 2023 Annual Conference

Life Sciences Times - 0
1...394041...91Page 40 of 91

Most Read